CXXC5 and obesity disorder: Consistent with reduced obesity, HFD‐fed Cxxc5−/− mice exhibited markedly improved glucose tolerance and insulin sensitivity (Figure 2C–E), with improved levels of metabolic parameters, including leptin, resistin, adiponectin, TGs, total cholesterol and HDL‐cholesterol levels (Figure S4).